COSTA MESA, Calif.--(BUSINESS WIRE)--May 4, 2006--Valeant Pharmaceuticals International (NYSE:VRX - News) today announced 2006 first quarter results. The company also announced that its restructuring initiative is on track and is targeting expense reductions in 2006 of approximately $20-30 million.
